Skip to main content
. 2024 May 27;10(2):20552173241257876. doi: 10.1177/20552173241257876

Table 3.

Comparison of pre- and post-rituximab ARR.

Group N Pre-rituximab Post-rituximab p value
Relapses Relapses
Events ARR (95% CI) Events ARR (95% CI)
Total 37 50 0.366 (0.271–0.483) 26 0.136 (0.088–0.201) <0.001
AQP-4-IgG-positive 27 38 0.375 (0.264–0.517) 15 0.097 (0.053–0.163) <0.001
Seronegative with patient 26 10 12 0.339 (0.175–0.592) 11 0.278 (0.139–0.497) 0.432
Seronegative without patient 26 9 11 0.314 (0.157–0.562) 5 0.133 (0.043–0.311) 0.313